Recent developments in the application of natural pigments as pH-sensitive food freshness indicators in biopolymer-based smart packaging : challenges and opportunities

DATA AVAILABILITY STATEMENT : Data sharing is not applicable to this article as no new data were generated or analysed during this study.Recently, the assimilation of pH-sensitive natural pigments into biopolymers has shown promising prospects for pH-reactive based smart packaging material. Unlike synthetic pigments, which have potential safety problems due to migration, natural pigments have negligible toxicity levels both to humans and the environment and some even possess nutritional and pharmacological properties. To complement the advantages of natural pigments, natural biopolymers have proven to be ideal candidates for the development of smart packaging because of their biocompatibility, availability, biodegradability, stability, minimum toxicity and good film-forming capability. Smart packaging gives consumers real-time signals on the quality of packaged food via food deterioration indicators like pH alteration. This review will consider the recent progress in the development of pH-responsive smart packaging based on natural pH-sensitive pigments and natural biopolymers from 2013 to the present. It will further discuss the challenges and opportunities of colorimetric smart packaging.University Research Committee, University of Johannesburg.https://onlinelibrary.wiley.com/journal/13652621hj2024Consumer ScienceFood ScienceSDG-02:Zero Hunge

Selenium nanoparticles–enhanced potato starch film for active food packaging application

This work developed an active selenium nanoparticles-based potato starch film. The incorporation of selenium nanoparticles (SeNPs) improved the microstructure, physical and biological properties of the nanocomposite film. Scanning electron microscopy (SEM) showed a slight increase in surface roughness and heterogeneity of nanocomposite film. Addition of SeNPs resulted in an improvement in film thickness and density from 0.02 ± 0.01 to 0.04 ± 0.00 mm and 1.01 ± 0.12 to 1.31 ± 0.03 g cm−3, respectively, while water content, film solubility, swelling degree as well as water vapour transmission rate decreased. Integration of SeNPs into potato starch film caused a significant change (P < 0.05) of colour to red (a*) and yellow (b*). The tensile strength also improved with addition of SeNPs from 3.42 to 9.86 MPa. The presence of SeNPs in the potato starch film enhanced its antioxidant and antimicrobial activity. The overall migration and specific migration were within acceptable levels as stipulated in the EU regulations. The findings of this study present an alternative biodegradable biopolymer material that can be used as active food packaging material in replacement of nonbiodegradable synthetic polymer material.Centre for Nanomaterials Science Research; DST-NRF Centre of Excellence - Smart Foods; Thuthuka National Research Foundation; University of Johannesburg; Water Research Commission.https://onlinelibrary.wiley.com/journal/13652621hj2023Consumer ScienceFood Scienc

Observation of the out-of-plane magnetization in a mesoscopic ferromagnetic structure superjacent to a superconductor

The geometry of magnetic flux penetration in a high temperature superconductor at a buried interface was imaged using element-specific x-ray excited luminescence. We performed low temperature observation of the flux penetration in YBa2Cu3O7–δ (YBCO) at a buried interface by imaging of the perpendicular magnetization component in square Permalloy (Py) mesostructures patterned superjacent to a YBCO film. Element specific imaging below the critical temperature of YBCO reveals a cross-like geometry of the perpendicular magnetization component which is decorated by regions of alternating out-of-plane magnetization at the edges of the patterned Py structures. The cross structure can be attributed to the geometry of flux penetration originating from the superconductor and is reproduced using micromagnetic simulations. Our experimental method opens up possibilities for the investigation of flux penetration in superconductors at the nanoscale

Lifestyle intervention prior to IVF does not improve embryo utilization rate and cumulative live birth rate in women with obesity:a nested cohort study

STUDY QUESTION: Does lifestyle intervention consisting of an energy-restricted diet, enhancement of physical activity and motivational counseling prior to IVF improve embryo utilization rate (EUR) and cumulative live birth rate (CLBR) in women with obesity? SUMMARY ANSWER: A 6-month lifestyle intervention preceding IVF improved neither EUR nor CLBR in women with obesity in the first IVF treatment cycle where at least one oocyte was retrieved. WHAT IS KNOWN ALREADY: A randomized controlled trial (RCT) evaluating the efficacy of a low caloric liquid formula diet (LCD) preceding IVF in women with obesity was unable to demonstrate an effect of LCD on embryo quality and live birth rate: in this study, only one fresh embryo transfer (ET) or, in case of freeze-all strategy, the first transfer with frozen-thawed embryos was reported. We hypothesized that any effect on embryo quality of a lifestyle intervention in women with obesity undergoing IVF treatment is better revealed by EUR and CLBR after transfer of all fresh and frozen-thawed embryos. STUDY DESIGN, SIZE, DURATION: This is a nested cohort study within an RCT, the LIFEstyle study. The original study examined whether a 6-month lifestyle intervention prior to infertility treatment in women with obesity improved live birth rate, compared to prompt infertility treatment within 24 months after randomization. In the original study between 2009 and 2012, 577 (three women withdrew informed consent) women with obesity and infertility were assigned to a lifestyle intervention followed by infertility treatment (n = 289) or to prompt infertility treatment (n = 285). PARTICIPANTS/MATERIALS, SETTING, METHODS: Only participants from the LIFEstyle study who received IVF treatment were eligible for the current analysis. In total, 137 participants (n = 58 in the intervention group and n = 79 in the control group) started the first cycle. In 25 participants, the first cycle was cancelled prior to oocyte retrieval mostly due to poor response. Sixteen participants started a second or third consecutive cycle. The first cycle with successful oocyte retrieval was used for this analysis, resulting in analysis of 51 participants in the intervention group and 72 participants in the control group. Considering differences in embryo scoring methods and ET day strategy between IVF centers, we used EUR as a proxy for embryo quality. EUR was defined as the proportion of inseminated/injected oocytes per cycle that was transferred or cryopreserved as an embryo. Analysis was performed per cycle and per oocyte/embryo. CLBR was defined as the percentage of participants with at least one live birth from the first fresh and subsequent frozen-thawed ET(s). In addition, we calculated the Z-score for singleton neonatal birthweight and compared these outcomes between the two groups. MAIN RESULTS AND THE ROLE OF CHANCE: The overall mean age was 31.6 years and the mean BMI was 35.4 ± 3.2 kg/m(2) in the intervention group, and 34.9 ± 2.9 kg/m(2) in the control group. The weight change at 6 months was in favor of the intervention group (mean difference in kg vs the control group: −3.14, 95% CI: −5.73 to −0.56). The median (Q25; Q75) number of oocytes retrieved was 4.00 (2.00; 8.00) in the intervention group versus 6.00 (4.00; 9.75) in the control group, and was not significantly different, as was the number of oocytes inseminated/injected (4.00 [2.00; 8.00] vs 6.00 [3.00; 8.75]), normal fertilized embryos (2.00 [0.50; 5.00] vs 3.00 [1.00; 5.00]) and the number of cryopreserved embryos (2.00 [1.25; 4.75] vs 2.00 [1.00; 4.00]). The median (Q25; Q75) EUR was 33.3% (12.5%; 60.0%) in the intervention group and 33.3% (16.7%; 50.0%) in the control group in the per cycle analysis (adjusted B: 2.7%, 95% CI: −8.6% to 14.0%). In the per oocyte/embryo analysis, in total, 280 oocytes were injected or inseminated in the intervention group, 113 were utilized (transferred or cryopreserved, EUR = 40.4%); in the control group, EUR was 30.8% (142/461). The lifestyle intervention did not significantly improve EUR (adjusted odds ratio [OR]: 1.36, 95% CI: 0.94–1.98) in the per oocyte/embryo analysis, taking into account the interdependency of the oocytes per participant. CLBR was not significantly different between the intervention group and the control group after adjusting for type of infertility (male factor and unexplained) and smoking (27.5% vs 22.2%, adjusted OR: 1.03, 95% CI: 0.43–2.47). Singleton neonatal birthweight and Z-score were not significantly different between the two groups. LIMITATIONS, REASONS FOR CAUTION: This study is a nested cohort study within an RCT, and no power calculation was performed. The randomization was not stratified for indicated treatment, and although we corrected our analyses for baseline differences, there may be residual confounding. The limited absolute weight loss and the short duration of the lifestyle intervention might be insufficient to affect EUR and CLBR. WIDER IMPLICATIONS OF THE FINDINGS: Our data do not support the hypothesis of a beneficial short-term effect of lifestyle intervention on EUR and CLBR after IVF in women with obesity, although more studies are needed as there may be a potential clinically relevant effect on EUR. STUDY FUNDING/COMPETING INTEREST(S): The study was supported by a grant from ZonMw, the Dutch Organization for Health Research and Development (50-50110-96-518). A.H. has received an unrestricted educational grant from Ferring pharmaceuticals BV, The Netherlands. B.W.J.M. is supported by an NHMRC Investigator grant (GNT1176437). B.W.J.M. reports consultancy for Guerbet, has been a member of the ObsEva advisory board and holds Stock options for ObsEva. B.W.J.M. has received research funding from Guerbet, Ferring and Merck. F.J.M.B. reports personal fees from membership of the external advisory board for Merck Serono and a research support grant from Merck Serono, outside the submitted work. TRIAL REGISTRATION NUMBER: The LIFEstyle RCT was registered at the Dutch trial registry (NTR 1530). https://www.trialregister.nl/trialreg/admin/rctview.asp?TC=1530

Why Give Birth in Health Facility? Users' and Providers' Accounts of Poor Quality of Birth Care in Tanzania.

In Tanzania, half of all pregnant women access a health facility for delivery. The proportion receiving skilled care at birth is even lower. In order to reduce maternal mortality and morbidity, the government has set out to increase health facility deliveries by skilled care. The aim of this study was to describe the weaknesses in the provision of acceptable and adequate quality care through the accounts of women who have suffered obstetric fistula, nurse-midwives at both BEmOC and CEmOC health facilities and local community members. Semi-structured interviews involving 16 women affected by obstetric fistula and five nurse-midwives at maternity wards at both BEmOC and CEmOC health facilities, and Focus Group Discussions with husbands and community members were conducted between October 2008 and February 2010 at Comprehensive Community Based Rehabilitation in Tanzania and Temeke hospitals in Dar es Salaam, and Mpwapwa district in Dodoma region. Health care users and health providers experienced poor quality caring and working environments in the health facilities. Women in labour lacked support, experienced neglect, as well as physical and verbal abuse. Nurse-midwives lacked supportive supervision, supplies and also seemed to lack motivation. There was a consensus among women who have suffered serious birth injuries and nurse midwives staffing both BEmOC and CEmOC maternity wards that the quality of care offered to women in birth was inadequate. While the birth accounts of women pointed to failure of care, the nurses described a situation of disempowerment. The bad birth care experiences of women undermine the reputation of the health care system, lower community expectations of facility birth, and sustain high rates of home deliveries. The only way to increase the rate of skilled attendance at birth in the current Tanzanian context is to make facility birth a safer alternative than home birth. The findings from this study indicate that there is a long way to go

Consumption of Malay Herbal Medicine (MHMs) during pregnancy and postpartum

All around, natural medication is an undeniably sought after elective drug. They had been expended for ages to enhance one’s prosperity. In Malaysia, Malay home grown medications (MHMs) are ordinarily expended amid pregnancy and baby blues by moms of the Malay people group. This investigation is a similar poll consider including 106 baby blues Malay moms; comprising of 64 customers and 42 nonshoppers. Respondents were met amid their postnatal visits to decide their socioeconomics, example of MHMs’ utilization and pregnancy and neonatal qualities. Top three MHMs devoured were Ubat Periuk (12.5%, n=8), Manjakani (26.6%, n=17) and Nona Roguy repression set (20.3%, n=13). Utilization of MHMs amid pregnancy did not impact preterm conveyance and in addition neonatal birth weight, birth length, and head boundary. The revealed chances proportion for neonatal jaundice and requirement for phototherapy were 1.03 and 2.78 separately. Then, moms who did not expend MHMs amid pregnancy revealed bring down occurrences (p<0.05) and bring down hazard (OR=0.25) of undermined premature births. Higher dangers of neonatal jaundice were found for baby blues utilization. As an end, family unit salary was an affecting statistic factor for MHMs utilization. Requirement for phototherapy about tripled with pregnancy utilization; while, non-utilization seems, by all accounts, to be defensive against undermined fetus removal

Inter-Observer Variation in the Pathologic Identification of Minimal Extrathyroidal Extension in Papillary Thyroid Carcinoma

Background: Extrathyroidal extension (ETE) is a significant prognostic factor in papillary thyroid carcinoma (PTC). Minimal extrathyroidal extension (mETE) is characterized by involvement of the sternothyroid muscle or perithyroid soft tissue, and is generally identified by light microscope examination. Patients with mETE, identified pathologically, are automatically upstaged to pT3. However, the prognostic implications of mETE have been a source of controversy in the literature. Moreover, there is also controversy surrounding the identification of mETE on pathological specimens. The objective of this study was to determine the level of agreement among expert pathologists in the identification of mETE in PTC cases. Methods: Eleven expert pathologists from the United States, Italy, and Canada were asked to perform a review of 69 scanned slides of representative permanent sections of PTC specimens. Each slide was evaluated for the presence of mETE. The pathologists were also asked to list the criteria they use to identify mETE. Results: The overall strength of agreement for identifying mETE was slight (??=?0.14). Inter-pathologist agreement was best for perithyroidal skeletal muscle involvement (??=?0.46, moderate agreement) and worst for invasion around thick-walled vascular structures (??=?0.02, slight agreement). In addition, there was disagreement over the constellation of histologic features that are diagnostic for mETE, which affected overall agreement for diagnosing mETE. Conclusions: Overall agreement for the identification of mETE is poor. Disagreement is a result of both variation in individual pathologists' interpretations of specimens and disagreement on the histologic criteria for mETE. Thus, the utility of mETE in staging and treatment of PTC is brought into question. The lack of concordance may explain the apparent lack of agreement regarding the prognostic significance of this pathologic feature.Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/140271/1/thy.2015.0508.pd